biotech · Recurrent Plasma Cell Myeloma · Anal Cancer Metastatic · ONCY
Oncolytics Biotech
ONCOLYTICS BIOTECH INC
Oncolytics Biotech trial registry — 24 ClinicalTrials.gov studies with program phase, status, and indication context.
4350 Executive Dr, 325, San Diego, California 92121, US HQ
1998 Founded
46 Employees
Public company Type
ONCY · NYSE Ticker
Company details
- Status
- Public
- HQ
- 4350 Executive Dr, 325, San Diego, California 92121, US
- Founded
- 1998
- Employees
- 46
- Programs
- 23
- Drugs
- 14
- Patents
- 66
Oncolytics Biotech clinical trials
Registry index of 24 ClinicalTrials.gov studies linked to Oncolytics Biotech programs — each row shows trial ID, program name, phase, status, and indication.
Oncolytics Biotech trial registry — 24 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Oncolytics Biotech.
-
REO 029 — Phase 2
Clinical update -
Lenalidomide or Pomalidomide — Phase 1
Clinical update -
Docetaxel, Reolysin and Prednisone — Phase 2
Clinical update -
REOLYSIN® — Phase 1
Clinical update -
REOLYSIN — Phase 3
Clinical update -
Bevacizumab — Phase 2
Clinical update -
Folfox plus Bevacizumab and reolysin — Phase 2
Clinical update -
Paclitaxel — Phase 2
Clinical update